IMUGENE LIMITED — Director's Dealing 2026

May 14, 2026

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Leslie Chong
Date of last notice	22 April 2026

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder)	N/A
Date of change	11 May 2026 to 14 May 2026
No. of securities held prior to change	(1) 2,683,835 - Direct Ordinary Fully Paid Shares
(2)220,718 - Indirect Ordinary Fully Paid Shares
(3)597,059 - Employee Share Option Plan - Options
(4)1,518,441 - Employee Share Option Plan - Performance Rights
(5)85,785 - OPTIONS @ $4.012 EXP 31/08/2026
Class	(1) Direct Ordinary Fully Paid Shares
Number acquired	230,285 (11 May 2026) Direct Fully Paid Shares
355,164 (13, 14 May 2026) Direct Fully Paid Shares
Number disposed	NIL
Value/Consideration	(11 May 2026) $0.1075 Per Ordinary Fully Paid Share
(13,14 May 2026) $0.1025 Per Ordinary Fully Paid Share

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

---

Appendix 3Y

Change of Director's Interest Notice

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2